 When Nimbus Therapeutics set up shop in 2009, it had to convince the industryincluding its founding chief scientific officerthat virtual drug discovery could be a viable approach. Now, Nimbus is unveiling four new programs its been working on, which could lead to treatments for metabolic disorders, cancer and autoimmune disease. 